Esterhuizen, Karien
Lindeque, J. Zander
Mason, Shayne
van der Westhuizen, Francois H.
Rodenburg, Richard J.
de Laat, Paul
Smeitink, Jan A. M.
Janssen, Mirian C. H.
Louw, Roan http://orcid.org/0000-0002-6542-8644
Funding for this research was provided by:
TIA (Metabol. 01)
Article History
Received: 4 September 2020
Accepted: 31 December 2020
First Online: 12 January 2021
Compliance with ethical standards
:
: The authors declare no competing interests. Jan Smeitink is the founding CEO of Khondrion.
: The study complied with all Institutional guidelines and terms of the Declaration of Helsinki of 1975 (as revised in 2013) for investigation of human participants. Ethical approval was obtained from the Health Research Ethics Committee (HREC) of the North-West University, South Africa (NWU-00170-13-S1) and the Ethics Committee of the Nijmegen-Arnhem region of the Netherlands (2010/183; NL32683.091.10). All the patients, as well as the controls, provided written informed consent for their urine samples to be used for these research purposes.